Anhui Huaheng Biotechnology Co., Ltd.

SHSE:688639 Stok Raporu

Piyasa değeri: CN¥8.3b

Anhui Huaheng Biotechnology Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 2/6

Anhui Huaheng Biotechnology kazançlarla iyi bir şekilde karşılanan, 1.7% cari getiriye sahip, temettü ödeyen bir şirkettir.

Anahtar bilgiler

1.7%

Temettü verimi

0.4%

Geri Alım Getirisi

Toplam Hissedar Getirisi2.1%
Gelecekteki Temettü Verimi3.0%
Temettü Büyümesin/a
Bir sonraki temettü ödeme tarihin/a
Eski temettü tarihin/a
Hisse başına temettüCN¥0.621
Ödeme oranı48%

Son temettü ve geri alım güncellemeleri

Güncelleme yok

Recent updates

Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Soars 35% But It's A Story Of Risk Vs Reward

Oct 21
Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Soars 35% But It's A Story Of Risk Vs Reward

Here's Why We Think Anhui Huaheng Biotechnology (SHSE:688639) Is Well Worth Watching

Oct 14
Here's Why We Think Anhui Huaheng Biotechnology (SHSE:688639) Is Well Worth Watching

Slammed 29% Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Screens Well Here But There Might Be A Catch

Sep 05
Slammed 29% Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Screens Well Here But There Might Be A Catch

Anhui Huaheng Biotechnology's (SHSE:688639) Profits Appear To Have Quality Issues

Sep 03
Anhui Huaheng Biotechnology's (SHSE:688639) Profits Appear To Have Quality Issues

Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Analysts Just Cut Their EPS Forecasts Substantially

Sep 02
Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Analysts Just Cut Their EPS Forecasts Substantially

Many Would Be Envious Of Anhui Huaheng Biotechnology's (SHSE:688639) Excellent Returns On Capital

Aug 20
Many Would Be Envious Of Anhui Huaheng Biotechnology's (SHSE:688639) Excellent Returns On Capital

Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Jul 22
Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Anhui Huaheng Biotechnology Co., Ltd.'s (SHSE:688639) Intrinsic Value Is Potentially 43% Above Its Share Price

Jul 12
Anhui Huaheng Biotechnology Co., Ltd.'s (SHSE:688639) Intrinsic Value Is Potentially 43% Above Its Share Price

Is Anhui Huaheng Biotechnology (SHSE:688639) Using Too Much Debt?

Jun 21
Is Anhui Huaheng Biotechnology (SHSE:688639) Using Too Much Debt?

Take Care Before Jumping Onto Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Even Though It's 27% Cheaper

Jun 05
Take Care Before Jumping Onto Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Even Though It's 27% Cheaper

We Ran A Stock Scan For Earnings Growth And Anhui Huaheng Biotechnology (SHSE:688639) Passed With Ease

May 12
We Ran A Stock Scan For Earnings Growth And Anhui Huaheng Biotechnology (SHSE:688639) Passed With Ease

Earnings Report: Anhui Huaheng Biotechnology Co., Ltd. Missed Revenue Estimates By 37%

Apr 23
Earnings Report: Anhui Huaheng Biotechnology Co., Ltd. Missed Revenue Estimates By 37%

Anhui Huaheng Biotechnology Co., Ltd.'s (SHSE:688639) Business Is Trailing The Market But Its Shares Aren't

Mar 18
Anhui Huaheng Biotechnology Co., Ltd.'s (SHSE:688639) Business Is Trailing The Market But Its Shares Aren't

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: Temettü ödemeleri istikrarlı olsa da 688639 10 yıldan az bir süredir temettü ödüyor.

Büyüyen Temettü: 688639 şirketinin temettü ödemeleri artmış, ancak şirket yalnızca 2 yıldır temettü ödemiştir.


Piyasaya Karşı Temettü Getirisi

Anhui Huaheng Biotechnology Piyasaya Karşı Temettü Getirisi
688639 temettü verimi piyasa ile karşılaştırıldığında nasıldır?
SegmentTemettü Verimi
Şirket (688639)1.7%
Pazarın Alt %25'i (CN)0.5%
Pazarın En İyi %25'i (CN)2.1%
Sektör Ortalaması (Chemicals)1.7%
Analist tahmini (688639) (3 yıla kadar)3.0%

Önemli Temettü: 688639 'in temettüsü ( 1.7% ), CN piyasasındaki temettü ödeyenlerin en alttaki %25'inden ( 0.54% ) daha yüksektir.

Yüksek Temettü: 688639 'in temettüsü ( 1.7% ), CN piyasasındaki temettü ödeyenlerin en üst %25'ine ( 2.13% ) kıyasla düşüktür.


Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: Oldukça düşük ödeme oranı ( 47.8% ) ile 688639 'un temettü ödemeleri kazançlarla oldukça iyi bir şekilde karşılanıyor.


Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: 688639 temettü ödüyor ancak şirketin serbest nakit akışı yok.


Güçlü temettü ödeyen şirketleri keşfedin